Chronic myelogenous leukemia primitive hematopoietic progenitors demonstrate increased sensitivity to growth factor-induced proliferation and maturation

Experimental Hematology

Volumn 28, Issue 12, 2000, Pages 1401-1412

  Bhatia, Ravi ^a   Munthe, Heidi A ^a   Williams, Andrea D ^a   Zhang, Feiyu ^a   Forman, Stephen J ^a   Slovak, Marilyn L ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Chronic myelogenous leukemia; Differentiation; Growth factors; Proliferation; Stem cells

Indexed keywords

CD34 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; INTERLEUKIN 3; STEM CELL FACTOR; THROMBOPOIETIN;

ARTICLE; BONE MARROW CELL; CELL CYCLE; CELL MATURATION; CELL PROLIFERATION; CHRONIC MYELOID LEUKEMIA; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG EFFECT; FLUORESCENCE IN SITU HYBRIDIZATION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0034537334     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(00)00545-2     Document Type: Article

References (40)

1. A new consistent chromosome abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa staining
2. A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukemia
3. Induction of chronic myelogenous leukemia in mice by the p210 bcr/abl gene of the Philadelphia chromosome
4. Transformation of an interleukin-3-dependent hematopoietic cell line by the chronic leukemia-specific P210 bcr/abl protein
5. Frequency of clonal B lymphocytes in chronic myelogenous leukemia evaluated by fluorescence in situ hybridization
6. Which compartments are involved in Philadelphia-chromosome positive chronic myeloid leukaemia?
7. Lineage involvement of stem cells bearing the philadelphia chromosome in chronic myeloid leukemia in the chronic phase as shown by a combination of fluorescence-activated cell sorting and fluorescence in situ hybridization
8. Unresponsiveness of primitive chronic myeloid leukemia cells to macrophage inflammatory protein 1α, an inhibitor of primitive normal hematopoietic cells
9. MCP-1, not MIP-1α, is the endogenous chemokine that cooperates with TGF-β to inhibit the cycling of primitive normal but not leukemic (CML) progenitors in long-term human marrow cultures
10. Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia; decreased adhesion to stroma and fibronectin but increased adhesion to the basement membrane components laminin and collagen type IV
11. Interferon-α restores normal β 1 integrin-mediated inhibition of hematopoietic progenitor proliferation by the marrow microenvironment in chronic myelogenous leukemia
12. Direct adhesion to bone marrow stroma via fibronectin receptors inhibits hematopoietic progenitor proliferation
13. Growth factor-mediated terminal differentiation of chronic myeloid leukemia
14. Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia
15. Growth factor independence and BCR/ABL transformation; promise and pitfalls of murine model systems and assays
16. BCR-ABL accelerates C2-ceramide-induced apoptosis
17. Apoptosis in chronic myeloid leukaemia; normal responses by progenitor cells to growth factor deprivation, X-irradiation and glucocorticoids
18. New understanding of the pathogenesis of CML; a prototype of early neoplasia
19. + cells
20. Selective expansion of primitive normal hematopoietic cells in cytokine-supplemented cultures of purified cells from patients with chronic myeloid leukemia
21. Autocrine production and action of IL-3 and granulocyte colony-stimulating factor in chronic myeloid leukemia
22. Interferon-α restores normal adhesion of chronic myelogenous leukemia hematopoietic progenitors to bone marrow stroma by correcting impaired β 1 integrin receptor function (see comments)
23. Abnormal function of the bone marrow microenvironment in chronic myelogenous leukemia; role of malignant stromal macrophages
24. A clinically suitable ex vivo expansion culture system for LTC-IC and CFC using stroma-conditioned medium
25. + cells from patients with chronic myeloid leukemia
26. BCR/ABL negative primitive progenitors suitable for transplantation can be selected from the marrow of most early-chronic phase but not accelerated-phase chronic myelogenous leukemia patients
27. Murine stromal cells counteract the loss of long-term culture-initiating cell potential induced by cytokines in CD34(+)CD38(low/neg) human bone marrow cells
28. + mobilized peripheral blood stem cells
29. Soluble factor(s) produced by human bone marrow stroma increase cytokine-induced proliferation and maturation of primitive hematopoietic progenitors while preventing their terminal differentiation
30. Ex vivo expansion of murine marrow cells with interleukin-3 (IL-3), IL- 6, IL-11, and stem cell factor leads to impaired engraftment in irradiated hosts
31. Self-renewal of primitive human hematopoietic cells (long-term culture-initiating cells) in vitro and their expansion in defined medium
32. Direct evidence for multiple self-renewal divisions of human in vivo repopulating hematopoietic cells in short-term culture
33. Alternative signals to RAS for hematopoietic transformation by the BCR-ABL oncogene
34. Phosphatidylinositol-3 kinase activity is regulated by BCR/ABL and is required for the growth of Philadelphia chromosome-positive cells
35. P210 and P190(BCR/ABL) induce the tyrosine phosphorylation and DNA binding activity of multiple specific STAT family members
36. Functional heterogeneity of human CD34(+) cells isolated in subcompartments of the G0/G1 phase of the cell cycle
37. Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia
38. Rapid decline of chronic myeloid leukemic cells in long-term culture due to a defect at the leukemic stem cell level
39. Characterization of primitive subpopulations of normal and leukemic cells present in the blood of patients with newly diagnosed as well as established chronic myeloid leukemia
40. Adhesion to fibronectin maintains regenerative capacity during ex vivo culture and transduction of human hematopoietic stem and progenitor cells